Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities

References

• Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. The epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, . Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366–1377.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Trick WE, Fridkin SK, Edwards JR, . Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 2002; 35: 627–630.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Hollis RJ, . Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol 2009; 47: 3185–3190.
   PubMed Web of Science ®Google Scholar
• Kao AS, Brandt ME, Pruitt RW, . The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164–1170.
   PubMed Web of Science ®Google Scholar
• Hajjeh RA, Sofair NA, Harrison LH, . Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519–1527.
   PubMed Web of Science ®Google Scholar
• Lott TJ, Frade JP, Lockhart SR. MLST analysis reveals both clonality and recombination in Candida glabrata bloodstream isolates from US surveillance. Eukaryotic Cell 2010; 9: 619–625.
   Google Scholar
• Urwin R, Maiden CJ. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol 2003; 11: 479–487
   PubMed Web of Science ®Google Scholar
• Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryotic Cell 2008; 7: 1075–1084.
   PubMedGoogle Scholar
• Deak E, Etienne KA, Lockhart SR, . Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance. Can J Microbiol 2010; 56: 348–351.
   Google Scholar
• Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 2003; 41: 5709–5717.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard-M27-A3 3rd. Wayne, PA: Clinical Laboratory Standards Institute, 2008.
   Google Scholar
• Peakall R, Smouse PE. GENALEX 6: genetic analysis in Excel. Population genetic software for teaching and research. Mol Ecol Notes 2006; 6: 288–295.
   Web of Science ®Google Scholar
• Yeh FC, Boyle TJ. Population genetic analysis of co-dominant and dominant markers and quantitative traits. Belgian J Bot 1997; 129: 157.
   Google Scholar
• Lockhart, SR, Joly S, Vargas K, . Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J Dent Res 1999; 78: 857–868.
   Google Scholar
• Bennett JE, Izumikawa K, Marr KA. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2001; 48: 1773–1777.
   Google Scholar
• Mann PA, McNicholas PM, Chau AS, . Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. Antimicrob Agents Chemother 2009; 53: 5026–5034.
   PubMed Web of Science ®Google Scholar
• Tsai HF, Sammons LR, Zhang X, . Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob Agents Chemother 2010; 54: 3308–3317.
   Web of Science ®Google Scholar
• Enache-Angoulvant A, Bourget M, Brisse S, . Multilocus microsatellite markers for molecular typing of Candida glabrata: application to the analysis of genetic relationships between bloodstream and digestive isolates. J Clin Microbiol 2010; 48: 4028–4034.
   Web of Science ®Google Scholar
• Chapeland-Leclerc F, Hennequin C, Papon N, . Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob Agents Chemother 2010; 54: 1360–1362.
   PubMedGoogle Scholar
• Safdar A, Chaturvedi V, Koll BS, . Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999). Antimicrob Agents Chemother 2002; 46: 3268–3272.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, . Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis 2010; 67: 162–171.
   PubMed Web of Science ®Google Scholar
• Odds FC, Hanson MF, Davidson AD, . One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56: 1066–1075.
   PubMed Web of Science ®Google Scholar
• Lin CY, Chen YC, Lo HJ, Chen KW, Li SY. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol 2007; 45: 2452–2459.
   Google Scholar
• Colombo AL, Guimarães T, Silva LR, . Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570–576.
   PubMed Web of Science ®Google Scholar
• Flórez C, Martín-Mazuelos E, Ruiz M, . In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia. Enferm Infecc Microbiol Clin 2009; 27: 518–522.
   Google Scholar
• Jung SI, Shin JH, Song JH, . Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea. Med Mycol 2010; 48: 669–674.
   PubMed Web of Science ®Google Scholar
• Metwally L, Walker MJ, Coyle PV, . Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001–2006. J Infect 2007; 55: 174–178.
   PubMed Web of Science ®Google Scholar
• Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007; 35: 256–259.
   PubMed Web of Science ®Google Scholar
• Kaur R, Castano I, Cormack BP. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Chemother 2004; 48: 1600–1613.
   PubMed Web of Science ®Google Scholar